Strata Competitors
| SRTA Stock | 4.72 0.16 3.28% |
Strata Critical vs Universal Logistics Correlation
Poor diversification
The correlation between Strata Critical Medical and ULH is 0.68 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Strata Critical Medical and ULH in the same portfolio, assuming nothing else is changed.
Moving together with Strata Stock
Moving against Strata Stock
| 0.6 | PBCRF | PT Bank Central | PairCorr |
| 0.58 | CMWCF | Cromwell Property | PairCorr |
| 0.56 | KWO | Transport International | PairCorr |
| 0.41 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.38 | 81211KAY6 | Sealed Air Corp | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Strata Critical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Strata Critical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Strata Critical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Strata and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Strata Critical Medical does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Strata Stock performing well and Strata Critical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Strata Critical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AIRO | 4.37 | (0.77) | 0.00 | (0.17) | 0.00 | 10.18 | 23.45 | |||
| MTRX | 2.03 | (0.06) | (0.01) | 0.01 | 4.37 | 3.71 | 21.68 | |||
| EVTL | 3.83 | 0.11 | 0.02 | 0.19 | 5.31 | 9.38 | 32.52 | |||
| CYRX | 2.05 | 0.08 | 0.03 | 0.13 | 2.58 | 4.90 | 13.14 | |||
| ZIP | 3.23 | (1.07) | 0.00 | (0.38) | 0.00 | 5.02 | 18.26 | |||
| EBF | 0.99 | 0.25 | 0.19 | 0.47 | 0.93 | 2.20 | 6.77 | |||
| ORN | 2.91 | 0.57 | 0.21 | 0.30 | 2.61 | 5.81 | 25.03 | |||
| FLYX | 7.45 | 0.52 | 0.06 | 0.51 | 7.93 | 11.96 | 161.87 | |||
| KFRC | 2.25 | 0.54 | 0.27 | 0.68 | 1.75 | 3.82 | 33.33 | |||
| ULH | 3.55 | (0.10) | 0.01 | 0.02 | 3.89 | 8.52 | 18.95 |
Cross Equities Net Income Analysis
Compare Strata Critical Medical and related stocks such as AIRO Group Holdings, Matrix Service, and Vertical Aerospace Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIRO | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (20.5 M) | (25.6 M) | (32.5 M) | (38.7 M) | (34.8 M) | (36.6 M) |
| MTRX | 700 K | 17.2 M | 24 M | 35.8 M | 17.2 M | 28.9 M | (183 K) | (11.5 M) | 28 M | (33.1 M) | (31.2 M) | (63.9 M) | (52.4 M) | (25 M) | (29.5 M) | (26.5 M) | (25.2 M) |
| EVTL | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (12.3 M) | (245.2 M) | (94.4 M) | (59.9 M) | (781.2 M) | (703.1 M) | (668 M) |
| CYRX | (1 M) | (7.8 M) | (6.4 M) | (19.6 M) | (7 M) | (9.8 M) | (13.1 M) | (7.9 M) | (9.6 M) | (18.3 M) | (32.7 M) | (275.5 M) | (275.5 M) | (37.3 M) | (99.6 M) | (89.6 M) | (85.1 M) |
| ZIP | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | 86 M | 3.6 M | 61.5 M | 49.1 M | (12.9 M) | (11.6 M) | (11 M) |
| EBF | 11.4 M | 24.7 M | 24.7 M | 13.2 M | (44.5 M) | 1.8 M | 1.8 M | 32.9 M | 37.4 M | 24.1 M | 24.1 M | 29 M | 47.3 M | 40.2 M | 40.2 M | 42.6 M | 23.8 M |
| ORN | 4.9 M | (13.1 M) | (11.9 M) | 331 K | 6.9 M | (8.1 M) | (3.6 M) | 400 K | (94.4 M) | (5.4 M) | 20.2 M | (14.6 M) | (12.6 M) | (17.9 M) | (1.6 M) | (1.5 M) | (1.6 M) |
| FLYX | 7 M | 7 M | 7 M | 7 M | 7 M | 7 M | 7 M | 7 M | 7 M | 7 M | 7 M | 8.1 M | 6 M | (46.8 M) | (21.1 M) | (19 M) | (18 M) |
| KFRC | (600 K) | 27.2 M | (13.7 M) | 10.8 M | 90.9 M | 42.8 M | 32.8 M | 33.3 M | 58 M | 130.9 M | 56 M | 75.2 M | 75.4 M | 61.1 M | 50.4 M | 58 M | 60.9 M |
| ULH | 3.9 M | 15.8 M | 47.7 M | 50.6 M | 45.4 M | 40 M | 24.2 M | 28.2 M | 52.2 M | 37.6 M | 48.1 M | 73.7 M | 168.6 M | 92.9 M | 129.9 M | 149.4 M | 156.9 M |
Strata Critical Medical and related stocks such as AIRO Group Holdings, Matrix Service, and Vertical Aerospace Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Strata Critical Medical financial statement analysis. It represents the amount of money remaining after all of Strata Critical Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Strata Critical Competitive Analysis
The better you understand Strata Critical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Strata Critical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Strata Critical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Strata Critical Competition Performance Charts
Five steps to successful analysis of Strata Critical Competition
Strata Critical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Strata Critical Medical in relation to its competition. Strata Critical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Strata Critical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Strata Critical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Strata Critical Medical, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Strata Critical position
In addition to having Strata Critical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Iron Thematic Idea Now
Iron
Companies involved in production of steel and iron. The Iron theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Iron Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Strata Critical Correlation with its peers. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Ground Transportation space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Strata Critical. If investors know Strata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Strata Critical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.24) | Revenue Per Share | Quarterly Revenue Growth 2.083 | Return On Assets | Return On Equity |
The market value of Strata Critical Medical is measured differently than its book value, which is the value of Strata that is recorded on the company's balance sheet. Investors also form their own opinion of Strata Critical's value that differs from its market value or its book value, called intrinsic value, which is Strata Critical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Strata Critical's market value can be influenced by many factors that don't directly affect Strata Critical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Strata Critical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Strata Critical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Strata Critical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.